In conclusion, up-regulated HHLA2 level indicates severer pathology and worse prognosis for different cancers, such as clear cell renal cell carcinoma (ccRCC), intrahepatic cholangiocarcinoma (ICC) and osteosarcoma (15–17). Here, HHLA2 is linked to cancer.